Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA appointment

This article was originally published in The Tan Sheet

Executive Summary

David Acheson, MD, will lead the Food Safety & Security Staff at the Center for Food Safety & Applied Nutrition, agency announces Feb. 2. He will remain CFSAN's Chief Medical Officer while providing "leadership across a wide range of food safety and security issues currently facing FDA," an 1agency release says. Acheson will report to CFSAN head Robert Brackett, PhD, who took office Jan. 1 (2"The Tan Sheet" Dec. 8, 2003, p. 11)...

You may also be interested in...



CFSAN’s Levitt Unexpectedly Retires; Brackett To Take Over

FDA Center for Food Safety & Applied Nutrition's new Director Robert Brackett, PhD, brings a background in food microbiology and a focus on counter-terrorism to the position, following the retirement of current head Joseph Levitt

Moderna Stands Alone With Single-Antigen Approach To COVID-19 Vaccine

Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.

Kansas City TCM Firm Persists With COVID-19 Claims Following US Regulators' Warning

Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.

Topics

UsernamePublicRestriction

Register

PS096452

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel